SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
224 hedge funds and large institutions have $2.17B invested in Sage Therapeutics in 2021 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 90 increasing their positions, 67 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
45% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 58
55% less call options, than puts
Call options by funds: $15.4M | Put options by funds: $34.5M
Holders
224
Holding in Top 10
3
Calls
$15.4M
Puts
$34.5M
Top Buyers
| 1 | +$42.4M | |
| 2 | +$37.4M | |
| 3 | +$28.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$23.4M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$16.2M |
Top Sellers
| 1 | -$86.4M | |
| 2 | -$54.3M | |
| 3 | -$43.3M | |
| 4 |
Jennison Associates
New York
|
-$33.1M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$27M |